Publication | Closed Access

Inhibition of farnesyl pyrophosphate synthase attenuates angiotensin II-induced cardiac hypertrophy and fibrosis in vivo

Molecular PharmacologyHypertensionIi-induced Cardiac HypertrophyMolecular PhysiologyCardiomyopathyCardiovascular DiseaseBiochemistryFarnesyl Pyrophosphate SynthaseMedicinePhysiologyCardiovascular PharmacologyPharmacologyCardiologyOxidative Stress